C-VWDEGordian Biotechnology
in vivo drug discovery, Mosaic Screening, transcriptomics
discoverydiscoveringgene therapy
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-VWDE
C-VWDEC-VWDEin vivo drug discovery, Mosaic Screening, transcriptomics
0-100 chain-logic scale · 15 dimensions · scored on public evidence
The GRIP (Gordian Robotic Integrated Port Closure) Study is a prospective, single-arm feasibility study evaluating the use of the TroClose™ 1200 device for closure of da Vinci® 12 mm robotic assistant port sites following robotic-assisted surgical procedures. TroClose™ 1200 is an FDA-cleared medical device designed to facilitate fascial closure of laparoscopic and robotic access ports. The device deploys anchors and suture at the beginning of the procedure, allowing closure to be completed at the end of surgery without the need for additional needle passage or specialized closure instruments. The purpose of this study is to assess the safety, feasibility, procedural performance, and clinical outcomes associated with use of the device in patients undergoing robotic-assisted surgery. Study assessments will include successful port-site closure, device-related adverse events, post-operative complications, and short-term follow-up evaluations. Approximately 26 adult participants undergoing robotic-assisted surgical procedures at Allegheny Health Network will be enrolled.
Francisco LePort, CEO of Gordian Biotechnology, talks about new models for drug discovery at Progress Conference 2025: “Today, every age-related disease requires specialized expertise, experimentation, and equipment to solve. Learning the mechanisms of even one disease can take a lifetime (or more!). Yet all life springs from the same fundamental chemical processes. The vast complexity we see, including all of these diseases we wish to cure, stem from relatively small changes in the DNA based coding system shared across all biological systems. Can we design a drug discovery system with today’s tools that takes advantage of this? Can we scale drug discovery across all age-related diseases, rather than attacking each individually? What are the building blocks of such a discovery system, and how would this impact not just the science of drug discovery, but how it is funded and implemented?”
Pharma’s standard playbook—testing drugs in millions of identical plastic wells—misses the complexity of how diseases actually behave in living systems. In this clip, Francisco LePort and Martin Borch Jensen from Gordian Bio explain a new way forward: testing drugs in realistic biological environments that reflect how organs, cells, and tissues truly interact. Instead of assuming how disease works, they measure it directly—revealing which treatments have real potential to succeed in humans. Tune in to the full episode on: 💜 Apple Podcasts: https://podcasts.apple.com/us/podcast/ron-weiss-building-biological-neural-networks-to-fight/id1829721662?i=1000728267915 💚 Spotify: https://open.spotify.com/episode/0P2a5F2CAsDi9BqyXUQTv6?si=8f05b3d8263f48a1 ❤️ YouTube: https://www.youtube.com/watch?v=Qr3KXxUaim #DrugDiscovery #Biotech #MedicalResearch #PharmaInnovation #ScientificBreakthroughs #Podcas
What if the entire drug discovery industry has been doing preclinical testing backwards? Francisco LePort and Martin Borch Jensen, co-founders of Gordian Bio, think they've cracked the code on why so many promising therapies fail in clinical trials. Instead of testing potential drugs in simplified lab conditions, they're doing discovery directly in live animals with actual disease using a technique called pooled in vivo perturb-seq that can turn one horse into the equivalent of thousands of experiments. In this episode we discuss: - Why aging research ignores actual aging biology—and how this kills drug development - How to do the work of 10,000+ animal studies in a single experiment using gene therapy and single-cell sequencing - The policy disasters strangling US biotech innovation (and why China's gaining ground) - Why horses make better osteoarthritis models than injured young mice - How failed clinical trials waste billions in data that never gets analyzed This conversation dive
Francisco LePort, PhD Co-Founder and CEO, Gordian Biotechnology
Francisco LePort, Gordian Biotechnology, spoke on how their novel in vivo screening platform radically improves drug development for complex diseases of aging. Lightning Talk at Foresight Institute's Longevity Investment Take-off: What's Different & What's Missing? Salon info: https://foresight.org/longevity-investment-take-off-salon/ All videos: https://www.youtube.com/channel/UCg5UVUMqXeCQ03MelT_RXMg/playlists Sign up to Foresight's newsletter to stay informed on future events: bit.ly/foresightnews Foresight Institute is a non-profit institute for selectively advancing crucial technologies for the benefit of life, focused on nanotechnology, biotechnology, and AI. Join us: ► Twitter: https://twitter.com/foresightinst ► Facebook: https://www.facebook.com/foresightinst ► Instagram: https://www.instagram.com/existentialhope/ ► LinkedIn: https://www.linkedin.com/company/foresight-institute ► Support to join: https://foresight.org/donate/membership/ Foresight Institute advances t
The use of the TroClose1200™ will be done in at least one 12mm planned access port per the TroClose1200™ Instruction for Use. The procedure will be performed routinely. Adverse Events and device malfunctions, if any, will be recorded. Subjects will be hospitalized in accordance with the hospital guidance. All subjects will be followed at 2 weeks (+/- 4 days), at 6 weeks (+/- 1 week), at 12 months (+/- 1 month) and at 24 months (+/- 2 months) in which healing, signs of hernia and adverse events will be recorded. In the 12 and 24 months visit, the hernia signs will be evaluated by ultrasound.
XBRL Viewer Please enable JavaScript to use the EDGAR Inline XBRL Viewer.
PK!��lʪ� [Content_Types].xml �(�Ė�n�0 ��'� ��N4��i�(\�p�!m{���P�M�Ĝ�~.4M@� �Rk��~;m��`Q�� �όNX'n��4*��}}�� X�Qh%r�!aK�lп��}.-����O��>r�� �ccAS$5�H�ṋ��b ��n�si4�����{�TLs�^��r� �,z�KV�y&R�ϴ�Ci� 1U�r�$����I(#��w��DC��M����)���T ���Ӥi&a[_�Yg$xO3/�x)D�7��������E�[�D*a`�\ka��`.~��I�Am0�il�kM�V� ��3Ϡ��h����`�.��ھ@#� 2U��v�&fb�ȹ�*h��U�>)�n�R��ٻ(�GA��zڃ%=�} 3�ϭ�w�ު(� �T�т� ^(��mG�K�� u��F��������S�/8��Mל!&"r���O1��D� ��t�Eٚۢ���n�$�?m7���n�h�^�nb~����-_�h6����zlb��%����[-�������*=��@�t�Cc�v��W�'� �� �~ϰ�^=+a�"��n��c�P�Zgb>��� p��
%PDF-1.7 %���� 792 0 obj > endobj 808 0 obj >/Filter/FlateDecode/ID[ ]/Index[792 26]/Info 791 0 R/Length 94/Prev 789240/Root 793 0 R/Size 818/Type/XRef/W[1 3 1]>>stream h�bbd```b``�"׀�8��DrHS����H2���A���dS��A$�2H������9#�r�9 �D����� `�8- endstream endobj startxref 0 %%EOF 817 0 obj >stream h�b``�a``Z������:� 20EY8��?l`�q0b`Ix~�������*T���"����X�ՔA�Q�i;;Úƛmm�>BwYߗ�c~g�����R(3?�'� ��@��;p� X�tۏ��~ �����R! P endstream endobj 793 0 obj >/Metadata 189 0 R/PageLayout/OneColumn/Pages 789 0 R/StructTreeRoot 222 0 R/Type/Catalog>> endobj 794 0 obj >/E … ab90354-ce5a-4216-b520-17b27db7e794 uuid:dfac6ba1-c75a-4287-a6ce-a20f46040b97 6 application/pdf Devin Reed Adobe PDF Library 23.3.20 D:20230713205010 endstream endobj 190 0 obj >stream h�2��T0P0�4P06W���w�/�+Q0���L)� (��T��$����a*2)R0��� �E�@5�`�P 0�% i endstream endobj 191 0 obj >stream h�L�K �0࿒��A�M��@�xQAT�6+�GW�T�7UAos���0 ��hZ�#q���Vb�h�hF�+V� ��MWM���T��a��$H�X�Y ɰ I��mynZ2ډu>_�3��J �Ş�,�y������d0��d]H?���%z�P�-(��`͍7{�'!��Ts������P',���Yw� �
Job Order Contracting (JOC) | Gordian --> Skip to content Login Gordian Cloud Platform eGordian Sightlines Member Portal RSMeans Data Online VFA Support Portal Logo Home Solutions For Contractors Job Order Contracting Cost Estimating Bid Opportunities Commercial For Industry Owners A/E/C Commercial Federal Healthcare Higher Education K-12 State & Local Canada Public Sector UK Public Sector Co-op/GPO Partnerships By Capability Planning Develop data-driven capital strategies Procurement Deliver critical projects Optimization Maintain and improve asset performance View Platform Capabilities P … ontractors to help ensure your program meets your inclusion goals. Our software application also tracks your KPIs, so you know how your program is performing at all times. Job Order Contracting 101 From understanding the basics to accessing a program and beyond, this video series explains how JOC benefits procurement officials, facilities leaders, construction contractors and communities. Watch Now Job Order Contracting has been an instrumental tool in our entire suite of con … Projects with a Fixed Budget The City of Victorville (CA) used JOC to maximize grant funds and expend them on deadline. You can too. Replacement-In-Kind Projects When you need to replace an item without needing to change design specs, like this cafeteria ceiling tile replacement . 5 Simple Steps to Smarter Construction Procurement Joint Scope Meeting Detailed Scope of Work Price Proposal Price Proposal Review Job Order Issued Gordian schedules a meeting at the site for those … describes the work the contractor will perform. The contractor prepares a Price Proposal by selecting the appropriate tasks from Gordian’s Construction Cost Catalog® (CTC). Gordian reviews the Price Proposal to ensure the contractor has selected the appropriate tasks and quantities. Once the Price Proposal is approved, you issue a Job Order for the contractor to proceed. The Gordian Difference: Why Thousands of Organizations Partner With Us Programs Built With Purpose From se … your fingertips. Elevate your JOC program with quick access to your CTC, Price Proposal version histories, project milestones, program insights and robust reports. Take an Interactive Tour Experienced JOC Experts to Support Your Staff Gordian has decades of experience helping implement and oversee Job Order Contracting programs — more than any o
Milestones | Fund Platform Growth Since 2005 Skip to content About Us About Us Regional Offering Leadership & Team Value Proposition Milestones Our Services Our Services Fund Platform Fund Solutions Private Wealth Solutions Recent Mandates VCC Regulation & Governance Regulation & Governance Risk Management Why Singapore Funds Partners Contact Us About Us About Us Regional Offering Leadership & Team Value Proposition Milestones Our Services Our Services Fund Platform Fund Solutions Private Wealth Solutions Recent Mandates VCC Regulation & Governance Regulation & Govern … Brothers Harriman mandate Japan Small Cap – Long Only February 2006 Tengu Japan Fund launched Japan Long Short April 2006 Josho Fund launched Long Short Quantitative August 2006 Bonsai Microcap trust launched Japan Micro Cap – Long Only August 2007 AMP Future Directions Fund mandate Japan Long Only Small Cap September 2007 Prestwick Trust launched Global Focused Fund of Funds December 2007 Gordian Capital joins AIMA December 2007 GOAUT flow through structure launched Asia Lon … on Gordian Capital moves office June 2009 New Era Trust launched Global Focused Fund of Funds July 2009 DBP Cayman Investment Trust launched Asset Backed Securities July 2009 Global SuperStar Trust launched Global Focused Fund of Funds August 2009 Asian RisingStar Trust launched Asian Focused Fund of Funds November 2009 Atom Japan Alpha Fund launched Japan Event Driven / Long Short April 2010 Start22 Fund launched Japan Long Short May 2010 Dynamic Fund launched Global Macro M … hed Japan Long Short May 2010 Dynamic Fund launched Global Macro May 2010 Topaz Fund launched Asset Backed Securities March 2011 Carnico Japan Fund launched Japan Long Short April 2011 Due to continued expansion Gordian Capital moves to a new office May 2011 Solidus Asian Long Short Fund launched Pan Asian Long Short September 2011 Khan Mongolia Equity Fund launched Long Only Mongolian Equities October 2011 CTA Series Trust launched Fund of CTA Managed Accounts December 2011 … 11 CTA Series Trust launched Fund of CTA Managed Accounts December 2011 Shin-Ka Fund launched Japan Long Short February 2012 Japan Multi Strategy Equity Fund launched Fund of Japanese Alternative Strategies April 2012 OK Fund launched Japan Long Short September 2012 Choi Falcon Asia Fund launched Pan Asian Long Short March 2013 Managed Account la
Gene Therapy for Common Diseases - Gordian Biotechnology Skip to main content Gordian Biotechnology Gordian Biotechnology Home Science The Gordian Platform Patient Avatars Mosaic Screening Pythia Company About Us Meet The Team Careers Culture Our Culture Aristotle’s Apprentices Library of Alexandria Blog Media Contact Careers Gene Therapy for Common Diseases March 21, 2025 • Martin Borch Jensen Chris Towne The following content was posted by Gordian chief technology officer Martin Borch Jensen on the Norn Group website. The Norn Group is a nonprofit research organization focuse
Digital Development Partnership Annual Report: Responding to the COVID-19 Crisis Who We Are News FEATURE STORY October 26, 2020 Digital Development Partnership Annual Report: Responding to the COVID-19 Crisis Email Print Tweet Share Share LinkedIn Digg 人人网 Stumble Upon Delicious 新浪微博 udhaya --> STORY HIGHLIGHTS The COVID-19 pandemic presented countries with unprecedented challenges this year, spurring widespread shutdowns, school and business closures, and job losses. Digital technologies have become a critical lifeline for people coping with social distancing and partners reacted swiftly to h
%PDF-1.6 %���� 1280 0 obj > endobj 1300 0 obj >/Filter/FlateDecode/ID[ ]/Index[1280 32]/Info 1279 0 R/Length 100/Prev 686612/Root 1281 0 R/Size 1312/Type/XRef/W[1 3 1]>>stream h�bbd```b``� "f�H�@��, ��X�E$�� 0yLn����pX�����f���ji ɘ�����}'0012����00�L�g��� ��WI endstream endobj startxref 0 %%EOF 1311 0 obj >stream h�b```�� � ��D@����9@�Y�7� �Y�ͼ������K� H�20ؿ��*��Uq�b �05Q=O endstream endobj 1281 0 obj >/Metadata 28 0 R/PageLayout/OneColumn/Pages 1278 0 R/StructTreeRoot 32 0 R/Type/Catalog>> endobj 1282 0 obj >/Font >/XObject >>>/Rotate 0/StructParents 0/Tabs/S/Type/Page> … 8fb94e-bcc5-421d-ae98-383977eaec8c uuid:5f5860cf-0d21-436a-9af7-9c16c9292a26 12 application/pdf Melissa Barton Adobe PDF Library 17.11.238 D:20240209213301 Maximum Computer Services endstream endobj 29 0 obj >stream h�242�P0P���w�/�+Q����L)�64�0 )�Ic0i &���%D"m����,H�HLO-��0�� endstream endobj 30 0 obj >stream h�l�AK�@�2�n6�[%��B��E� �7�S\m22�U��H) ��x|��j��r��+�j� ����q��(��uاA���q߱� LN�pD�� �0���]BU�[mo��+���n�r���Ғ��gj]�C�иw�L'bx!E��㗄i����xg��)d�B
%PDF-1.6 %���� 238 0 obj > endobj 252 0 obj >/Filter/FlateDecode/ID[ ]/Index[238 26]/Info 237 0 R/Length 83/Prev 290325/Root 239 0 R/Size 264/Type/XRef/W[1 3 1]>>stream h�bbd```b``���-`�,2 LN�LJ ��,� "��H�� R���H2��������&ׂā:H&�30��`݁ $ endstream endobj startxref 0 %%EOF 263 0 obj >stream h�b```�BV� � ��ea�8���ImfIer�`�Y���%��CM��� � &Nf�Fy{�Z �. V���Y� \,y���D2��k]��~& �U � +:Vut��� gxpiƋW�)g ��K��R�W�9A�q����H�z�9�K@� Q�n�("�if����eY1�� ��J��00pt40�v�������fb�CGT�Al �d�d�@(`` 0 w@���ܠʀ�[�P�A � ̛��48Aa���Ϡ�y�{��S &q^�\8ܒ … m 2018-10-09T11:17:08-05:00 2018-09-25T07:39:55-05:00 2018-10-09T11:17:08-05:00 application/pdf Morris v. GORDIAN TRADING LIMITED UK et al, 17-05030 (Bankr. D. Kan. Sep. 25, 2018) Doc. # 88 uuid:2ab6dddd-a2e1-434b-8837-b58d4d7a7674 uuid:425e8508-9ba4-4c76-b53b-02c98e0417ac iText® 5.5.9 ©2000-2015 iText Group NV (AGPL-version) endstream endobj 150 0 obj >stream hޔ�;�@ D��dm�'��4�4QD�("!@| n�fǡ��'� �z)Y��f�@� A��vb� ��Na���4��kD�d#��m�55�օ+0/D;�� h�a����m�`ZІ� endst
Participating Companies - BIO Investment & Growth Summit 2026 Skip To Main Content February 16-17, 2027 | Miami Beach HOME ABOUT Show submenu for: ABOUT EVENT OVERVIEW WHY ATTEND? FAQS SHARE ON SOCIAL MEDIA CONTACT US SCHEDULE PROGRAM Show submenu for: PROGRAM PROGRAM SPEAKERS ADVISORY COMMITTEE COMPANY PRESENTATIONS PRESENTING COMPANIES BIO Partnering™ Show submenu for: BIO Partnering™ BIO PARTNERING™ PARTICIPATING COMPANIES PARTICIPATING INVESTORS PARTNERING WEBINARS DOWNLOAD THE APP LOG IN TO BIO PARTNERING SPONSOR Show submenu for: SPONSOR Become a Sponsor 2026 Sponsors SEARCH More Sh … equired. Financial, legal, consulting (11) This field is required. Hedge/Mutual Fund (PM,Buy-Side Research) (4) This field is required. Individual Investor (2) This field is required. Institute, hospital research (2) This field is required. Investment bank (12) This field is required. Investor (buy-side or sell-side research) (10) This field is required. IT, information (4) This field is required. Medical device or technology (20) This field is required. Other products or ser … a. Please try again with different keywords or filters. Loading Loading Flip 3i Fund United States Flip Hedge/Mutual Fund (PM,Buy-Side Research) Flip 7 Hills Pharma, Inc. United States Flip Biotech or pharma, therapeutic R&D Flip 8 Prime Biosciences Flip Flip 8VC United States Flip Flip AAA Family Office Israel Flip Family Office Flip AB Science France Flip Biotech or pharma, therapeutic R&D Flip Abbhi Capital Flip Flip Abiozen United States Flip Biotech or pharma, th … ip BoJian Capital United States Flip VC/Corporate VC Flip BOLD Longevity Growth Fund United States Flip VC/Corporate VC Flip Boston Capital Investment Club United States Flip Angel Investing Flip Botanical Solution Inc United States Flip Biotech or pharma, therapeutic R&D Flip Breakthru Medicine's United States Flip Biotech or pharma, therapeutic R&D Flip Bridge United States Flip Other products or services Flip Brighton Capital, Ltd. United States Flip Family Office … rapeutic R&D Flip Fortress Investment Group United States Flip Hedge/Mutual Fund (PM,Buy-Side Research) Flip Forward Equity Partners United States Flip VC/Corporate VC Flip FreeMind Investments United States Flip VC/Corporate VC Flip Frontier Pharma United States Flip Biotech or pharma, therapeutic R&D Flip Fulcrum Therapeutics United Sta
National Restaurant Association Show | Gordian National Restaurant Association Show Map Your Show DOWNLOAD May 16- 19, 2026 Chicago, IL Menu See more links My Planner My Profile Sign Out Home Exhibitors Floor Plan Programming & Education Show Website My Show Planner See more links My Planner My Profile Sign Out Sending Email... There are no available appointments for this exhibitor. Saving... Saving... Gordian Booths Booth Locations Lakeside Center, Booths 9300 - 14200 — 11729 Notes Create or log in to My Show Planner to see Notes . About Gordian Product Categories Beverages > Non-Alcoho … s? No Primary Product Category Food Startup Company in Foodservice No FABI Award Winner National Restaurant Association Show • ©2026 All Rights Reserved Sitemap | XML Sitemap | Help | Privacy Policy
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Gordian Biotechnology – Jobs – Imagine | Johns Hopkins University Skip to content Skip to AI Search Skip to main nav Search Keywords Log in Sign up Imagine You Get Curious Getting Curious for the JHU Community Talk to People Talking to People in the JHU community Take Action Taking Action for the JHU Community Share Your Story Sharing Your Story for the JHU Community Recruit Talent from Hopkins How to Recruit from Hopkins Our Blog Why Recruit from Hopkins? JHU At-A-Glance Students and Schools Get Involved Talent for the Future Our Office Mentor at Hopkins Alumni Mentorship Alumni L
Canada Spousal PR Sponsorship | Does anyone get SOWP within a few weeks or 1 month
Exhibitor Service Center - Joint Engineer Training Conference & Expo Home About About JETC SAME National Awards & Medals - U.S. Army - U.S. Navy - U.S. Marine Corps - U.S. Air Force - U.S. Coast Guard - U.S. Public Health Service - National Oceanic & Atmospheric Administration Schedule Full Schedule Keynote Speakers PDH and AIA Credit Exhibits Exhibit Sales Information Download the Exhibitor List Exhibit Map Exhibitor FAQ Exhibitor Service Center (ESC) Sponsors Thank You Sponsors! Sessions Education Sessions Keynote Speakers PDH and AIA Credit Service Centers Attendee Service Center Exhibitor
Gordian Biotechnology | Biotech Careers Skip to main content Biotech Careers Contact Submit an Employer Contact Add an Employer Search Open main menu Contact Submit an Employer Contact Add an Employer Search Main navigation Careers Job Areas People Articles Videos Biotech Companies Biotech Jobs Business Areas Gordian Biotechnology Website: Gordian Biotechnology Business Area(s) Cell and Gene Therapy Aging Description Gordian Biotechnology is a therapeutics company focused on diseases of aging. Age-related diseases have complex etiologies that depend on interactions with the aged environment, a
Fuel Costs Impact Construction Markets and Supply Chains | Gordian posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Untangling The Gordian Knot - Vistex, Inc FR Solutions Business AI Industries Services À propos de nous Ressources VISTAS Contactez Solutions Business AI Industries Services À propos de nous Ressources VISTAS Français Solutions Processus Gestion des rabais Gestion des prix Gestion des canaux Demande de remboursement fournisseur Gestion des droits et des royalties Gestion des performances des ventes Gestion des promotions distributeur Gestion des données de base Produits Solutions pour SAP Solutions cloud pour tout ERP Analyse du marché IA commerciale Industries Agriculture Automobile L’industr
Gordian Wealth Advisors | Simplifying Complexity Home About Our Philosophy Investment Solutions Alternative Investments Our Team FAQs Portfolio Score Financial Planning Estate Planning Trusts Life Insurance Irrevocable Life Insurance Trust Wills Contact Login Disclosure disclosure Gordian Wealth Advisors LLC is a registered investment advisor with the SEC. INFORMATIONAL PURPOSES ONLY Nothing on this site is an offer or solicitation to buy or sell any security. Although the site may include investment-related information, nothing on the site is a recommendation that you purchase, sell or
gordian - B2B Marketing Exchange Emerald Media Network Demand Gen Report Follow Follow Follow Follow Follow ADVERTISEMENT JOIN THE WAITLIST SPONSOR February 22-24, 2027 • Omni La Costa Resort, Carlsbad, CA Show About B2BMX Attend Why Attend Sponsor Why Sponsor Become a Sponsor Conference Agenda Overview Sessions Speakers News Latest Demand Gen Report Subscribe Search for: Q Show About B2BMX Attend Why Attend Sponsor Why Sponsor Become a Sponsor Conference Agenda Overview Sessions Speakers News Latest Demand Gen Report Subscribe February 22-24, 2027 • Omni La Costa Resort, Carlsbad, CA JOIN THE … WAITLIST SPONSOR Search for: Q gordian by B2BMX Team | Mar 6, 2019 | 0 comments Submit a Comment Your email address will not be published. Required fields are marked * Comment * Name * Email * Website [show_promo] ADVERTISEMENT FAQ CONTACT US FOLLOW US ON Follow Follow Follow Follow Follow © 2026 Emerald X, LLC. All Rights Reserved ABOUT CAREERS AUTHORIZED SERVICE PROVIDERS EVENT STANDARDS OF CONDUCT Your Privacy Choices TERMS OF USE PRIVACY POLICY
IQ-EQ buys Gordian Capital – International Adviser Skip to content Contact Subscribe Regions United Kingdom Middle East Europe Asia Africa North America Latin America Industry Tax & Regulation Products Life Health & Protection People Moves Companies Offshore Bonds Retirement Technology Platforms Investment Equities Fixed Income Alternatives Multi Asset Property Macro Views Structured Products Emerging Markets Commodities IA 100 Best Practice Best Practice Awards Media Video Podcast Directory My IA Events IA Tax Panel IA Intermediary Panel About IA ANNOUNCEMENT: Read more financia … sion strategy IQ-EQ has announced the acquisition of institutional cross border fund platform Gordian Capital as part of its global expansion strategy. Gordian CEO and co-founder Mark Voumard will continue to head up the business and will join IQ-EQ’s Asia senior leadership team. Gordian will retain its name until Q2 2026 when the business will rebrand as IQ-EQ. With offices in Singapore, Tokyo, Hong Kong, Shanghai and Melbourne, Gordian currently manage US$17bn. Subject to a … ropean private equity firm Astorg; in 2022, Astorg raised a €1.3bn continuation fund to raise additional capital for IQ-EQ’s growth plans. Mark Pesco, group CEO at IQ-EQ said: “Asia has long been a key region for IQ-EQ, and the addition of Gordian Capital, alongside our recent acquisition of AMAL Group, underscores our commitment to expanding our presence and capabilities in this dynamic market.” Voumard added: “Becoming part of a global powerhouse of nearly 6,000-people oper … losed‑ended investment funds Investment Fortem Capital launches managed futures fund Latest news AI predicted to cause the biggest disruption to advisers’ businesses NEWSLETTER Sign Up for International Adviser Daily Newsletter subscribe View site map Privacy Policy Terms and Conditions Contact International Adviser --> Published by Money Map Media – part of G&M Media Ltd Copyright (c) 2024. International Adviser covers the global intermediary market that uses cross-bor
Gordian Biotechnology Gordian Biotechnology Data Senior Computational Biologist Data South San Francisco, CA View job Terms of service Privacy Cookies Powered by Rippling
ARDD conference: How to turn aging research into medicines | Martin Borch Jensen posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in … on patients could be. How to Enter: Email your submission to: [email protected] Deadline: July 28 Winner Announced: July 31 We'll cover the full registration for the winner. You bring your ideas and join the conversation. Even if you don't plan to enter, we'd love to hear your thoughts in the comments: What area of aging biology do you believe holds the most promise for translation right now? 23 1 Comment Like Comment Share Copy LinkedIn Facebook X Alex Zhavoronkov 11mo Repor … y and Searle Scholar Awards and Burroughs-Wellcome and Beckman New Investigator Award. In 1999, he was selected as Young Investigator of the Year by the American Society for Cell Biology. He is an inventor on nine U.S. patents, many related to his work on the Ubiquitin-Proteasome System. #GLP -1 #weightloss #wegovy #semiglutide #Tirzepatide #Mounjaro #ozempic Thanks go to Ray Deshaies, Ph.D. and Amgen , Anna Frejd & Ylva Hultman Linda Hewitt for arranging this discussion, … ssue welcomes submissions that address cutting-edge strategies, including: -The application of AI and machine learning for predicting drug-target interactions. -Structure-based drug design and the role of cryo-EM and crystallography. -The use of omics technologies to identify biomarkers for personalized therapies. -Advances in biologics, RNA-based therapeutics, and gene-editing approaches. Contribute your original research, reviews, or short communications to highlight these … ificant steps forward in developing safe and effective therapeutics. Submission Deadline: 28 February 2026 🗓️ We look forward to your valuable contributions! 🚀 Learn more and submit your manuscript here: https://lnkd.in/eQnFv9Y6 #DrugDiscovery #AIinPharma #MolecularBiology #MedicinalChemistry #Research #CallForPapers #Biotechnology Like Comment
Gordian Biotechnology, Inc. - Drug pipelines, Patents, Clinical trials - Synapse Products Data Feature Plans Request Demo Sign Up for Free Last update 11 May 2026 Gordian Biotechnology, Inc. Startups | Holding Company | 2018 | California, United States | 10-50 | www.gordian.bio Startups | Holding Company | 2018 | California, United States | 10-50 | www.gordian.bio Last update 11 May 2026 Overview Pipeline Deal Translational Medicine Profit Grant & Funding(NIH) Investment Financing Overview Basic Info Introduction Gordian Biotechnology, Inc. is a therapeutics company that specializes in the … , decision-ready target validation.” LePort said the firm’s overall goal is “to apply our platform where traditional discovery tools fall short – particularly in complex, multi-tissue diseases.” The Gordian-Pfizer collaboration “reflects that strategy,” he said. Financial details of the collaboration have not been disclosed. Apr 5, 2027 TO Apr 7, 2027 Lyon, France Europe's Largest Springtime Biotech Partnering Event 08 Jan 2026 · longevity.technology Gordian Bio inks obesity … itions of over 360K organizations with Synapse. login or view full example data Grant & Funding(NIH) Access more than 2 million grant and funding information to elevate your research journey. login or view full example data Investment Gain insights on the latest company investments from start-ups to established corporations. login or view full example data Financing Unearth financing trends to validate and advance investment opportunities. login or view full example data
Construction Technology Company Gordian to be Acquired by Fortis - GroundBreak Carolinas Skip to primary navigation Skip to main content Skip to primary sidebar Skip to footer Groundbreak Carolinas MENU MENU News Careers Resources 2020 ABC of the Carolinas EIC Awards AEC Industry Blogs AEC School Directory Asbestos Resources Content Marketing Coronavirus Resources Diversity and Inclusion Economic Forecasts GroundBreak Carolinas Newsletter Archive Health and Wellness New Silica Standard Resources Workforce Development Resources Subscribe GroundBreak Carolinas Your source for construction indust … AGC Honors Community Impact Efforts of 28 Companies Footer About GBC Contact Us Submit Editorial Submit Event Partnerships/Contributors Sponsorship Opportunities Join Our Mailing List " * " indicates required fields Comments This field is for validation purposes and should be left unchanged. Name * First Last Email * Organization Name * By clicking Submit you agree to our Privacy Policy and Terms of Use . CAPTCHA Δ Copyright © 2026 GroundBreak Carolinas LL
Jobs at Gordian Biotechnology | Fifty Years You are using an outdated browser. Please upgrade your browser to improve your experience and security. Home Companies Team We build Substack Initiatives 5050 Spinout Playbook Manifest Grants Events Progress Index Podcasts Translation Podcast Speed Podcast Our Way Jobs Powered by Consider Privacy Terms Be indispensable. © Fifty Years Industries, LLC
SRAPPA 2026 Regional Conference - APPA Skip to content We use cookies to offer you a great user experience, to recognize returning APPA members, and to analyze website traffic. By continuing to use our site you consent to the use of cookies. ACKNOWLEDGE in your cart View Cart Cart Join Login Contact About About Us Blog History Board of Directors Staff Committees Overview Business Partner Advisory Committee Community College Engagement Member Engagement International Alliance Partners Get Involved Members Become a Member Membership Categories Business Partner Membership Become a Business Partne … d, NC 28027 United States Register Now 388 Seats Remaining Purchase Sponsorship Submit Proposal Sponsor Attendee Scholarships Add to Calendar Apple Google Outlook Desktop Outlook 365 Other Calendars 388 Seats Remaining Menu Overview Hotel Sponsorships Call for Papers Women in Facilities Technical Tuesday Nascar Hall of Fame Agenda Attendee Scholarships Leading Today and Designing Tomorrow The SRAPPA Annual Conference is the premier gathering for facilities management professi … al time, ensuring no valuable connection goes unrecorded. Bronze Attendee Scholarship $1,600.00 Make a meaningful impact by sponsoring an Attendee Scholarship. Your sponsorship covers the cost of registration & travel for a deserving attendee, providing them with access to world-class education, networking opportunities, and industry insights. This highly visible sponsorship demonstrates your organization's commitment to community, inclusivity, and the advancement o … nsor, your donated product, experience, or service will be featured as a raffle prize, giving your brand prominent recognition during the drawing and across all related event communications. In-Kind Speaker Gift Show your appreciation for our distinguished speakers while elevating your brand with an In-Kind Speaker Gift Sponsorship. As the sponsor of this unique opportunity, your donated product, experience, or service will be presented as a gift to each of our keynote … . Conference Theme: Leading Today and Designing Tomorrow: SRAPPA invites you to submit a program proposal for the 2026 SRAPPA Annual Meeting and Tradeshow , an exceptional opportunity to contribute to a dynamic professional development experience for facilities professionals across the educational community. The Annual Meeting and Tradeshow bring
IQ-EQ acquires Gordian Capital Limited, Asia’s first and largest institutional cross-border fund platform and fund solutions provider - IQ-EQ | Astorg LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn … Gordian Capital Singapore – Asia’s first and largest institutional cross border fund platform and fund solutions provider. This transformative acquisition strengthens IQ-EQ ’s global footprint and positions the firm as the market leader in the fund platform business across Asia-Pacific. With an established presence in Singapore, Tokyo, Hong Kong, Shanghai and Melbourne - and expansion plans into the Middle East - Gordian Capital significantly enhances IQ-EQ’s regional capabil … supported its long-term growth strategy and raised a €1.3 billion continuation fund in 2022 to provide additional capital to fuel the company’s ambitious plans. This latest acquisition of Gordian Capital represents a further step in IQ-EQ’s global expansion strategy, and a step forward in its mission to serve institutional clients across key international markets. 👇𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝗺𝗲𝗻𝘁: https://ow.ly/efWn50Wt22W #AstorgPortfolio #Flasghip #Busin … es Gordian Capital Limited, Asia’s first and largest institutional cross border fund platform and fund solutions provider - IQ-EQ https://iqeq.com 124 2 Comments Like Comment Share Copy LinkedIn Facebook X Peter Jaeger Japan Country Head 11mo Report this comment Congratulations Alvaro and good luck Astorg Like Reply 1 Reaction Dr. Essam Assella 10mo Report this comment Congratulations! Like Reply 1 Reaction See more comments To view or add a comment, sign in More Re … rp has announced the final close of its $750 million Golden Horizon Cooperation Fund in partnership with China Investment Corporation (CIC). → Fund Size: $750 million → Key Partner: China Investment Corporation (CIC) → Geographic Focus: High-growth ventures in the GCC and China → Target Sectors: Consumer, healthcare, logistics, and business servi
Jobs at Gordian Biotechnology | age1 You are using an outdated browser. Please upgrade your browser to improve your experience and security. Join our talent network Powered by Consider Privacy Terms We fund healthy lifespan extension discover Vision FAQ Library social Twitter LinkedIn [email protected] PRIVACY POLICY AGE1 © 2026 ALL RIGHTS RESERVED
Sponsorship - RMA 2025 | Montana State University Search Search Search Search Search Site Menu expand Skip Navigation RMA 2025 Home Registration Schedule & Program Overview Hospitality & Travel Activities Sponsorship RMA 2025 Sponsorship Sponsorship Sponsors are a critical component to our conference helping add breadth and depth to the conference experience. This conference takes a new approach to sponsorship recognizing the value in sponsor/business partner & RMA APPA relationships. Check out the sponsorship opportunities we have available below. If you would like to
Does The Gordian Group, Inc Sponsor H1B & Green Card Visas? | Ellis Home Services Pricing About Resources Login Schedule a Call Services From employment-based visas to family petitions, adjustment of status, and everything in between—we handle all immigration matters. The options shown here are just some of our most common services. Get In Touch Visa Options H-1B $3,000 H-1B1 $3,000 TN $2,500 O-1 $12,000 L-1 $10,000 J-1 $2,500 E-1/E-2 $10,000 E-3 $3,000 Green Card Options EB-1A $12,000 EB-2 NIW $12,000 EB-2 PERM $12,000 EB-3 PERM $12,000 Other Naturalization $5,000 Resources Tools Visa Spo … mate your H-1B lottery chances News DHS Proposes 75% Increase to US Citizenship Application Fee Supreme Court Ruling on Birthright Citizenship: What It Means for Families H-1B Visa Update: $100,000 Fee Temporarily Reinstated Following Court Stay Judge Strikes Down Trump's $100,000 H-1B Visa Fee — But Can It Return? Is USCIS Really Ending Adjustment of Status? An Immigration Attorney's Analysis of the May 2026 Memo See all news Articles Birthright Citizenship in the
%PDF-1.7 4 0 obj > stream ����JFIF``��C !( !0*21/*.-4;[email protected]?]c\RbKSTQ��C''Q6.6QQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQ��a"�� ���}!1AQa"q2���#B��R��$3br� %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz��������������������������������������������������������������������������� ���w!1AQaq"2�B���� #3R�br� $4�%�&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz�������������������������������������������������������������������������� ?������
Gordian is North America’s leading provider of Job Order Contracting (JOC) programs. Watch this video to find out how a Gordian JOC program accelerates projects that matter. Visit https://bit.ly/3xnb5C7 for more information. | Gordian
Products | Gordian --> Skip to content Login Gordian Cloud Platform eGordian Sightlines Member Portal RSMeans Data Online VFA Support Portal Logo Home Solutions For Contractors Job Order Contracting Cost Estimating Bid Opportunities Commercial For Industry Owners A/E/C Commercial Federal Healthcare Higher Education K-12 State & Local Canada Public Sector UK Public Sector Co-op/GPO Partnerships By Capability Planning Develop data-driven capital strategies Procurement Deliver critical projects Optimization Maintain and improve asset performance View Platform Capabilities Products Gordian Clo … st serve the your community. Learn More Kykloud Kykloud is a surveying software application for mobile devices that collects and reports on facilities and asset condition data. This intuitive application can streamline your data collection process, build customizable survey forms and templates that meet your organization’s needs, and allows you to understand your data and run reports on your organization’s budget, cost and spend. Learn More Campus Sustainability Design and im
Francisco LePort - BIO Investment & Growth Summit 2026 Skip To Main Content February 16-17, 2027 | Miami Beach HOME ABOUT Show submenu for: ABOUT EVENT OVERVIEW WHY ATTEND? FAQS SHARE ON SOCIAL MEDIA CONTACT US SCHEDULE PROGRAM Show submenu for: PROGRAM PROGRAM SPEAKERS ADVISORY COMMITTEE COMPANY PRESENTATIONS PRESENTING COMPANIES BIO Partnering™ Show submenu for: BIO Partnering™ BIO PARTNERING™ PARTICIPATING COMPANIES PARTICIPATING INVESTORS PARTNERING WEBINARS DOWNLOAD THE APP LOG IN TO BIO PARTNERING SPONSOR Show submenu for: SPONSOR Become a Sponsor 2026 Sponsors SEARCH More Show more
The Power of Partnership in State and Local Governments Facilities Management | Gordian --> Skip to content Login Gordian Cloud Platform eGordian Sightlines Member Portal RSMeans Data Online VFA Support Portal Logo Home Solutions For Contractors Job Order Contracting Cost Estimating Bid Opportunities Commercial For Industry Owners A/E/C Commercial Federal Healthcare Higher Education K-12 State & Local Canada Public Sector UK Public Sector Co-op/GPO Partnerships By Capability Planning Develop data-driven capital strategies Procurement Deliver critical projects Optimization Maintain and impr … munities rely on daily, they lack the resources to build the case for and fully fund the projects that would most significantly move the needle. They see strategic partners as having a key role in helping them plan, procure and optimize facilities — in a cost-effective way. Access Now Share this: Have a Project in Mind? Streamline Your Construction Procurement Process, Connect with Qualified Contractors and Kickstart Your Project Now! Enter a Project Discover More Content Sav
--> Borch Jensen, Ph.D. | Barzilai Consulting top of page Home Affiliations Testimonials Longevity Consulting Advisory Speaker About the Speaker Speaking Topics Bookings and Media Meet David About Us Contact Extra Use tab to navigate through the menu items. Book Now < Back Foreword Author Martin Borch Jensen, Ph.D. Say Hello Say Hello Say Hello Say Hello View FOLS Martin Borch Jensen, PhD, works broadly to industrialize longevity. He is Co-founder and Chief Scientific Officer of Gordian Biotechnology, the first company to discover novel therapeutic targets for complex diseases through poole
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Gordian & Pfizer to advance in vivo target discovery for obesity BioXconomy is part of the Informa Connect Division of Informa PLC Informa PLC | ABOUT US | INVESTOR RELATIONS | TALENT This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726. About Events Advertise Stay Updated Stay Updated Partnering Related Topics Licensing M&A Growth Strategy Recent in Partnering See All Clinical Trials Saudi drug authority expands US … , decision-ready target validation.” LePort said the firm’s overall goal is “to apply our platform where traditional discovery tools fall short – particularly in complex, multi-tissue diseases.” The Gordian-Pfizer collaboration “reflects that strategy,” he said. Financial details of the collaboration have not been disclosed. BIO-Europe Spring Apr 5, 2027 TO Apr 7, 2027 | Lyon, France Europe's Largest Springtime Biotech Partnering Event REGISTER LEARN MORE REGISTER LEARN
Incubating Promising Drug Developers | Charles River Sorry, you need to enable JavaScript to visit this website. Skip to main content You are here Home Insights A Commitment to Incubating Promising Drug Developers Featured News May 06 2025 A Commitment to Incubating Promising Drug Developers Advanced therapy developers form part of our inaugural Incubator Program cohort The Charles River Incubator Program (CIP) aims to expedite the development of life-changing therapies for patients in need by offering early-stage biotechnology pioneers access to extensive scientific and commercial expertise a … eam will be in touch to discuss additional information required to support your application. Apply Today Gordian Bio Developing novel therapeutics for chronic conditions leveraging an innovative screening platform that measures in vivo efficacy and safety of thousands of novel gene targets simultaneously, in individual animal models of disease. "Our in vivo screening technology has rapidly identified multiple development candidates in osteoarthritis and heart failure, and is
Fruit Flies, Burning Man, and Creating Time: The Gordian Founding Story - Gordian Biotechnology | Martin Borch Jensen LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or s
Gordian Biotechnology Collaborates with Pfizer on Obesity Target Discovery | Chris Towne posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or … hat Gordian Biotechnology has announced a research collaboration with Pfizer to apply our in vivo mosaic screening platform to obesity target discovery. Drug discovery today isn’t limited by ideas, it’s limited by knowing which targets truly matter in a living system. This collaboration reflects a shared belief that large-scale, physiologically relevant in vivo validation is essential to de-risk targets early and improve downstream outcomes in complex metabolic disease. At Go … 6,254 followers 5mo Today, we announced a research collaboration with Pfizer to apply Gordian’s in vivo mosaic screening platform to obesity target discovery. Drug discovery is no longer limited by ideas, but by validation. The industry can generate associations and hypotheses at unprecedented scale, but knowing which targets actually change disease biology in a living organism remains slow and costly. That is the gap Gordian was built to close. Our platform is designed not j … 6,254 followers 5mo Today, we announced a research collaboration with Pfizer to apply Gordian’s in vivo mosaic screening platform to obesity target discovery. Drug discovery is no longer limited by ideas, but by validation. The industry can generate associations and hypotheses at unprecedented scale, but knowing which targets actually change disease biology in a living organism remains slow and costly. That is the gap Gordian was built to close. Our platform is designed not j … mo Report this post Today, we announced a research collaboration with Pfizer to apply Gordian’s in vivo mosaic screening platform to obesity target discovery. Drug discovery is no longer limited by ideas, but by validation. The industry can generate associations and hypotheses at unprecedented scale, but knowing which targets actually change dise
Decoding Diseases of Aging...Dr. Martin Borch Jensen and Dr. Francisco LePort, Gordian Biotechnology - Rapamycin Longevity News Rapamycin Longevity News Decoding Diseases of Aging...Dr. Martin Borch Jensen and Dr. Francisco LePort, Gordian Biotechnology RapAdmin January 8, 2026, 12:07am #1 This week on Biotech Nation, Dr. Martin Borch Jensen and Dr. Francisco LePort from Gordian Biotechnology share a bold new approach to fighting diseases of aging before they take hold. Instead of testing one drug at a time, their technology allows scientists to test hundreds of potential treatments at once, m … nown targets. I. Executive Summary The provided transcript focuses on Gordian’s application of in vivo single-cell screening to identify novel therapeutic targets for complex, age-related diseases (such as osteoarthritis and heart failure). The core thesis posits that complex diseases cannot be adequately modeled in vitro because the pathology often resides in the systemic interplay between diverse cell types (e.g., immune-fibroblast interactions) rather than within isolated
Francisco LePort · Gordian Biotechnology: Exploring the in vivo perturbome · SlidesLive EN Česky English Deutsch Get an estimate Services References Blog Careers Contact Library Download Recording App SlidesLive Categories EN Česky English Deutsch Log in Get an estimate ICML ICML 2019 ICML 2019 - Room 101 LIVE Gordian Biotechnology: Exploring the in vivo perturbome Gordian Biotechnology: Exploring the in vivo perturbome Jun 14, 2019 Speakers About The workshop will showcase recent research in the field of Computational Biology. There has been significant development in genomic se … like artificial intelligence, statistics and data science, as well as important application areas such as machine vision, computational biology, speech recognition, and robotics. ICML is one of the fastest growing artificial intelligence conferences in the world. Participants at ICML span a wide range of backgrounds, from academic and industrial researchers, to entrepreneurs and engineers, to graduate students and postdocs. Like the format? Trust SlidesLive to capture your ne
Gordian Biotechnology Introduces Mosaic Screening for Complex Disease Targets | HokKih Data Sciences posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continu … More details below: https://lnkd.in/e9aJVjHk Genome Canada and Ontario Genomics Award Specific Biologics and Western University $1.8 Million Grant to Develop a Machine Learning Platform to Accelerate the Development of the Company's Dualase®-based Therapeutics prnewswire.com 133 5 Comments Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in DIGZON 527 followers 3mo Report this post PDF Proteasomes : The World of Regulatory Proteolysis Wolfgang Hilt, … in Joe Fernandez 3mo Report this post I may be late to this, as the initial IND application cleared in late January, but the idea of reprogramming cells to regenerate damaged tissue is incredibly exciting. David Sinclair, a long-time Active Motif customer, is advancing toward first-in-human clinical trials in epigenetic reprogramming to treat optic nerve damage and restore vision. These efforts, developed through Life Biosciences, have received FDA IND clearance and are movin … en used clinically via stem cells, this represents one of the first attempts to apply partial epigenetic reprogramming directly in the body (in vivo)—allowing cells to retain identity while restoring function. This shifts the field from cell replacement toward true tissue rejuvenation. In preclinical models, this has already shown: • Regeneration of optic nerve cells • Restoration of vision • Reversal of epigenetic aging From an investment and strategy perspective, this is on … utics. https://lnkd.in/eRCxNPiA Life Biosciences Announces FDA Clearance of IND Application for ER-100 in Optic Neuropathies https://www.lifebiosciences.com 47 5 Comments Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Juliana Kostanyan 3mo Report this post 🔬 HER2 Amplification by FISH — In-Depth Clinical & Diag
VentureRadar 0){if($('#i_b_toggleMore').hasClass('active')){Search_Elastic();}else{Search_DeconstructSearchString();Search_Elastic(false);event.preventDefault();}}else{event.preventDefault();}}" onclick="this.removeAttribute('readonly');" ontouchstart="this.removeAttribute('readonly');" id="i_t_Search" name="VRSearch" readonly> All Ranked Organisation Names Apps and Links Homepage (myVR) Funding Deals Hub Similar Companies App Articles Manage Account Logout Login Free Sign-up Forgotten your password? By continuing, you agree to VentureRadar's Terms of Service , Privacy Policy and Cookie … de Therapies; Vaccines; Biotech Show more Show less Updates All Funding Insight Grant Award Conference Competition Research Website Traffic Trend Business InsighT 01 Dec 2020 Website traffic has increased in the past 3 months, up from a ranking of 676,733 to 376,314. Source: Data from alexa.com COVID-19 vaccine tracker - London School of Hygiene & Tropical Medicine Research Report 20 Sep 2020 [BioNTech; Fosun Pharma; Pfizer] listed among those developing/researching a COVID-1 … ene therapy to cost $850,000 per patient | Reuters Source: reuters.com The STEP Award (2011) Award 29 Nov 2011 Category Winner: Finances Source: The STEP Award (2011) Show less Funding Signals VENTURE FUNDED Venture-funding News Venture-funding News Venture-funding News Related Top Ranked Companies Lists Life Sciences Biologics Healthtech Sars-Cov-2 Vaccine Cancer Melanoma Immunotherapy Diagnostics Dna Rna Peptide Therapies Vaccines Biotech Website Archive 2022 2023 2024 2025 … search results. Please select a Type Funding Round Team Products & Technologies Grant Award Conference Competition Other {DETAIL_VALUE} Remove Upgrade for full access You have reached your free usage limit for today. Upgrade to a paid plan for: Unlimited search alerts 250 records per export Unlimited pages and searches Full Access from $ 60.00 per month Upgrade Now Your VentureRadar Business account is now active and your account information has been sent to … nditions Privacy Policy Cookie Policy Contact Us Twitter LinkedIn | Submit a Company Directory of Companies Login Free Sign-up for VentureRadar access or By continuing, you agree to VentureRadar's Terms of Service , Privacy Policy and Cookie Policy . Free Sign-up for VentureRadar access You must have cookies enabled to create an accou
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
#vitalistbay #longevity #geroscience #agingresearch #biotech | Vitalist Bay LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agree … 7 followers 3mo Edited Report this post Martin Borch Jensen received an NIH K99 award — one of the most competitive fellowships in academic science, designed to launch independent research careers. He returned it after one year to start a company. That company, Gordian Biotechnology , developed a screening platform that tests thousands of gene therapies simultaneously in living animals — in a real environment that resembles patients with age-related disease, not in plastic we
--> Kristen Fortney from BioAge Labs and Martin Borch Jensen from Gordian Biotechnology on longevity top of page HOME EVENTS LIC in Gstaad 2026 LIC in Gstaad 2025 LIC in Gstaad 2024 LIC in Gstaad 2023 LIC in Gstaad 2022 LIC (Virtual) 2021 LIC (Virtual) 2020 LIL in Davos 2026 LIL in Davos 2025 LIL in Davos 2024 LIL in Davos 2023 LIL in Davos 2022 XPRIZE Investor Summit 2025 TEAM PRESS LI News CONTACT More Use tab to navigate through the menu items. Kristen Fortney from BioAge Labs and Martin Borch Jensen from Gordian Biotechnology on longevity Eva Novak Mar 3, 2023 3 min read During the Longevi … onference, from giving a Longevity industry overview, talking about data and AI application in longevity to explaining how to bridge academia and business. Keep reading for some additional thoughts from Kristen Fortney, CEO and co-founder at BioAge and Martin Borch Jensen, Co-Founder and CSO at Gordian Biotechnology. Where do you see the biggest areas for improvement in the longevity field? What's holding them back? Kristen Fortney: Over the past 30 years, we’ve learned
Culture - Gordian Biotechnology Skip to main content Gordian Biotechnology Gordian Biotechnology Home Science The Gordian Platform Patient Avatars Mosaic Screening Pythia Company About Us Meet The Team Careers Culture Our Culture Aristotle’s Apprentices Library of Alexandria Blog Media Contact Careers Your browser does not support the video tag. Values Apprenticeship Library Of Alexandria Open Positions Employee Highlights Benefits Gordian Values Preface At Gordian, we believe that company values should guide us through difficult decisions that define who we are. The most useful values help us … ow to face every challenge, and you’ll do the same for others. You’ll learn and apply state-of-the-art scientific tools, decision-making frameworks, and biotech strategy. After a few years, you’ll look back at your past self and marvel that what felt daunting is now trivial. Aristotle’s Apprentices Join us on our quest to cure age-related disease and help people wake up every morning, more capable than the day before. Learn More Open Positions All Positions Library of Alexand … days, and encourage people to actually use them! Team Lunch Gordian provides a stipend to employees working in person out of our headquarters to order lunch through Forkable. Travel Benefit Employees who are able to use public transportation to get to the office (and avoid the use of a car) are eligible for a $250 / month commute stipend. Get to know the diverse and extraordinary Gordian team View More Home Science Company Culture Blog Media Contact Careers Gordian Biot
A Year of Turbo Growth: Inside Our 2025 Apprenticeship Program - Gordian Biotechnology Skip to main content Gordian Biotechnology Gordian Biotechnology Home Science The Gordian Platform Patient Avatars Mosaic Screening Pythia Company About Us Meet The Team Careers Culture Our Culture Aristotle’s Apprentices Library of Alexandria Blog Media Contact Careers A Year of Turbo Growth: Inside Our 2025 Apprenticeship Program February 10, 2026 • Gordian Biotechnology Last year, Gordian launched Aristotle’s Apprenticeship with our first cohort—Diego, Juana, Arthi, and Gayathri (pictured … , the message was consistent: don’t self‑select out, and don’t be quiet: Juana: Apply apply apply! Don’t discount yourself because you have little industry or academic lab experience. Arthi: Ask as many questions and talk to as many people as possible. Gayathri: Be thoughtful and thorough with everything you do… who uses it, how some results might be interpreted, and what context they need. Diego: There is so much to learn from the people around you. Pay attention to how peop … ty, initiative, and the willingness to become more capable than the day before. Apply Now Stay in the know Sign up for our newsletter for exclusive updates on Gordian. Enter email Leave this field empty if you're human: Share Read More February 10, 2026 A Year of Turbo Growth: Inside Our 2025 Apprenticeship Program Learn More about A Year of Turbo Growth: Inside Our 2025 Apprenticeship Program. August 8, 2025 Announcing the Winner of the Gordian Essay Contest: Soleil Ava Wizm
Expedition Infrastructure Partners & Gordian Group Form Strategic Alliance Skip to content About Investment Banking & Advisory Portfolio Valuation Principal Investing Insights News Thought Leadership Interviews Team Careers Contact Hamburger Toggle Menu Expedition Infrastructure Partners & Gordian Group Form Strategic Alliance Partnership combines $20B in renewable transactions with 35yrs of restructuring expertise NEW YORK – September 2025 – Expedition Infrastructure Partners (“XIP”) and Gordian Group (“Gordian”) today announced a strategic partnership to … entures, and power equipment manufacturers. “Our partnership allows us to apply restructuring expertise to renewable energy markets where regulatory changes create both risks and opportunities,” said Peter Kaufman , President of Gordian Group. The XIP-Gordian partnership provides comprehensive services including restructuring advisory, capital solutions, strategic advisory, and crisis management for renewable power sponsors and developers. Their focus is exclusive
Climate Finance Experts - Gordian Knot Strategies Skip to content About Expand Clients Testimonials Team CarbonAccess Expand TRARO®: Impact Investment Screening Expand Download Guide – Smarter Climate Investing: 7 Strategic Filters Before Your First Impact Dollar Case Studies CapitalCatalyst Expand Impact Investing Expand TRARO®: Impact Investment Screening Impact Investor Information Form U.S. Endowment for Forestry & Communities – Impact Investing Program Case Studies StrategySphere Expand Case Studies Insights Expand Newsletter Expand SLICED – Weekly Newsletter VIRTUS – … for Impact Credit Enhancement Facility for Assurance & Risk (CEFAR) Climate RFP Tracker CONTACT Search Toggle Menu Where Climate Capital Finds Its Way When climate finance feels intractable, the world’s leading impact investors, corporations, and project developers know who to trust. START THE CONVERSATION 47 CLIENTS SERVED 17 COUNTRIES SERVED 1566000000 $ MOBILIZED TO DATE ABOUT Gordian Knot Strategies is the specialist climate finance advisory firm that impact inv … nancial Officer Savory Institute It’s been fantastic working with GKS. The IFNF grant program has benefitted from GKS’ big-picture strategic thinking, and ability to connect strategy to less exciting but equally as important tactical decisions. Of the many positives, I’ve most appreciated GKS’ willingness to re-think assumptions, respond to group feedback and/or research takeaways, and adapt accordingly. They recognize the importance of problem identification, take time to ve … aggie Monast - Senior Director, Climate-Smart Agriculture Environmental Defense Fund GKS listens well. They know the carbon and impact investment space and bring much added expertise for us. You challenge us to think outside the box and use a well thought out process to tackle ideas. You are very well networked and those connections help you to see spaces that we have not even considered. Alicia Cramer – Sr. Vice President US Endowment for Forestry and Communities In addition … for Impact Credit Enhancement Facility for Assurance & Risk (CEFAR) Climate RFP Tracker Loading Comments... Write a Comment... Email (Required) Name (Required) Website Toggle Menu Close Search for: Search
Aristotle’s Apprentices - Gordian Biotechnology Skip to main content Gordian Biotechnology Gordian Biotechnology Home Science The Gordian Platform Patient Avatars Mosaic Screening Pythia Company About Us Meet The Team Careers Culture Our Culture Aristotle’s Apprentices Library of Alexandria Blog Media Contact Careers Aristotle’s Apprentices Join us on our quest to cure age-related disease and help people wake up every morning, more capable than the day before. A career-defining experience Aristotle’s Apprentices enjoy a holistic experience in early-stage biotech and play a pivotal role in subs
Get Gordian Ventures contact and information in the United States | Angels Partners Find Angel Investors Find Angel Investors in the US Find Angel Investors in the UK Find Angel Investors in Europe Find Angel Investors in Denmark Find Angel Investors in Finland Find Angel Investors in France Find Angel Investors in Germany Find Angel Investors in Italy Find Angel Investors in Netherlands Find Angel Investors in Sweden Find Angel Investors in Switzerland Find Angel Investors in Canada Find Angel Investors in Australia Top VC Firms Top AI VC firms Top BioTech VC firms Top CleanTech VC firms Top … complexities of product development, regulatory pathways, and market entry. The fund operates with an investment minimum of $100,000, ensuring they can make significant contributions to a startup's early funding rounds. However, they are capable of investing up to $1,500,000 per company, which they consider their investment 'sweet spot'. This level of investment enables them to play a meaningful role in the growth of the ventures they back, ensuring those compa
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Carmelo Michael Gordian | Professionals | Holland & Knight Skip to content Practices Professionals Industries Insights Events News Offices Careers Menu Refine search by section Refine Search Filters Full Site Professionals Practices Industries Insights Events News Case Studies View All Matching Results Carmelo Michael Gordian Partner Carmelo Michael Gordian Partner [email protected] Austin +1.512.404.6746 M: +1.512.426.3698 Practices Corporate Services | Emerging Companies | Venture Capital | Mergers and Acquisitions | Corporate Governance | Public Companies and Securities | Privat … cing and its $50 million Series A funding co-led by a corporate venture capital fund and a cybersecurity-focused venture capital firm, with participation from numerous other investors Represented an AI-based software company based in Norway in its $4.8 million Series Seed financing Represented a logistics company based in Chile in its $3.2 million Series A financing and convertible note financings Represented a cybersecurity company based in Austin in its $8 million Series Se … technology company with its various Series Seed financings Represented a hedge fund manager with its $3 million investment in an Israeli startup company developing solar geoengineering technology Corporate Venture Capital + Represented various insurance, banking, technology, consumer product and other corporate investors in numerous venture capital investments and secondary stock acquisitions Credentials Education Harvard Law School, J.D. Harvard University, B.A., Economics
%PDF-1.6 %���� 81 0 obj > endobj 100 0 obj >/Filter/FlateDecode/ID[ ]/Index[81 32]/Info 80 0 R/Length 92/Prev 95909/Root 82 0 R/Size 113/Type/XRef/W[1 3 1]>>stream h�bbd```b``� "��Iɲ ,� �f���v0�L���?`� ��c��y �k-��[$�^������>�U�I��� ��5 endstream endobj startxref 0 %%EOF 112 0 obj >stream h�b```�� , :[@��(������ČF��;3:�b(�!��џ����3�q��| � G��l�48 8?�o�4�������� ��|7����t%D��@��d� endstream endobj 82 0 obj >/Metadata 4 0 R/Pages 79 0 R/StructTreeRoot 8 0 R/Type/Catalog/ViewerPreferences >>> endobj 83 0 obj >/Font >/ProcSet[/PDF/Text/ImageC]/XObject >>>/Rot … Q�l�o�R_� endstream endobj 4 0 obj >stream Skia/PDF m139 Google Docs Renderer application/pdf 2025-06-13 Belmont - Comprehensive Capital Budget Committee Meeting 2025-06-20T09:15:19-04:00 2025-06-20T09:15:19-04:00 2025-06-20T09:15:19-04:00 uuid:d18d69f8-e326-415f-b320-d2afe5be6214 uuid:0a006d09-0c18-45c1-91d3-bce6b377776c endstream endobj 5 0 obj >stream h�2�T0P���w�/�+Q0���L)��0 )��X��ʂT�����b;;�&� endstream endobj 6 0 obj >stream h�|�� �@F�W�;u!^5%C\��J������qF�k�
Careers - Gordian Biotechnology Skip to main content Gordian Biotechnology Gordian Biotechnology Home Science The Gordian Platform Patient Avatars Mosaic Screening Pythia Company About Us Meet The Team Careers Culture Our Culture Aristotle’s Apprentices Library of Alexandria Blog Media Contact Careers Explore Career Opportunities All Positions Have a question? Let us know. Email Address * First Name * Last Name * Message Recruitment Notice Gordian only communicates via @gordian.bio email addresses for recruitment. We never conduct interviews via text message or request payment during hiring. C
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Careers - Gordian Biotechnology Skip to main content Gordian Biotechnology Gordian Biotechnology Home Science The Gordian Platform Patient Avatars Mosaic Screening Pythia Company About Us Meet The Team Careers Culture Our Culture Aristotle’s Apprentices Library of Alexandria Blog Media Contact Careers Explore Career Opportunities All Positions Have a question? Let us know. Email Address * First Name * Last Name * Message Recruitment Notice Gordian only communicates via @gordian.bio email addresses for recruitment. We never conduct interviews via text message or request payment during hiring. C
The Gordian Knot of Television | MIT Technology Review You need to enable JavaScript to view this site. Skip to Content MIT Technology Review Featured Topics Newsletters Events Audio MIT Technology Review Featured Topics Newsletters Events Audio Uncategorized The Gordian Knot of Television Simplifying TV is more of a business problem than a technology problem. By David Zax archive page November 30, 2012 TV is a Gordian Knot. Even from the standpoint of the consumer, the world is fragmented and confusing. We watch everywhere–on our phones, our tablets, our computers, or TV sets. We use a pletho
Gordian™ Surgical Surpasses 2,000 Surgeries with Its FDA-Cleared and CE-Marked TroClose™1200 Access-Closure System for Laparoscopic Surgery - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufactu … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Gordian™ Surgical Surpasses 2,000 Surgeries with Its FDA-Cleared and CE-Marked TroClose™1200 Access-Closure System for Laparoscopic Surgery April 3, 2019 | 2 min read Twitter LinkedIn Facebook Email Print Gordian Surgical, a commercial-stage medical device company with growing international sales of its innovative TroCl … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Gordian Surgical Completes $2.25 Million Raise and Receives FDA Clearance for Troclose1200 - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Ther … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search News FDA Gordian Surgical Completes $2.25 Million Raise and Receives FDA Clearance for Troclose1200 December 7, 2016 | 4 min read Twitter LinkedIn Facebook Email Print Gordian Surgical Completes $2.25 Million Raise and Receives FDA Clearance for TroClose1200™ MISGAV, Israel and TUTTLINGEN, Germany , D … nd distribution in U.S. and European markets. Concurrently, with the successful fund raising round, Gordian announced it received FDA regulatory clearance for its TroClose1200 , an innovative trocar with integrated closure system for the suturing of abdominal wall incisions during laparoscopic surgical procedures. The FDA approval follows Gordian's receipt of CE Mark certification as announced on 6 September 2016 . Gordian Surgical developed TroClose1200 to give sur … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Gordian Health Solutions Expands Facility, Attracts New Business - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Gordian Health Solutions Expands Facility, Attracts New Business February 28, 2006 | 2 min read Twitter LinkedIn Facebook Email Print NASHVILLE, Tenn., Feb. 27 /PRNewswire/ -- Gordian Health Solutions, Inc. is expanding its Franklin, Tennessee, operations to include an additional 18,000 square feet of space, which will … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Gordian Surgical Raises $3 Million for Commercialization of Its Laparoscopic Closure System - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene The … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search News Deals Gordian Surgical Raises $3 Million for Commercialization of Its Laparoscopic Closure System October 29, 2019 | 2 min read Twitter LinkedIn Facebook Email Print Gordian Surgical Ltd. a portfolio company of The Trendlines Group Ltd., is pleased to announce that it has raised $3 million. Investors … bsp; 2 min read · Tristan Manalac Podcast AbbVie keeps M&A rolling, FDA’s reversal train chugs along, BIO 2026 dispatch, more June 24, 2026 · 1 min read · Jef Akst BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. Explore News Jobs Newslett … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
IQ-EQ acquires Gordian Capital Limited, Asia’s first and largest institutional cross-border fund platform and fund solutions provider - IQ-EQ > uc_cmp_country, prevent double injection for CB and GTM --> --> IQ-EQ Locations People About Latest Technology Careers Search Make an enquiry Global SELECT YOUR LOCATION Global (English) LOCAL SITES Global (English) Australia (English) Belgium (English) Cayman Islands (English) China (English) Curaçao (English) Cyprus (English) France (English) Guernsey (English) Hong Kong (English) India (English) Ireland (English) Isle of Man (English) Japan (English … le menu Make an enquiry Home Locations People About Latest Careers All services Fund and Asset Managers Impact funds Digital assets Hedge funds Hybrid, evergreen and semi-liquid funds Real assets services Private debt and credit Open-ended funds Private equity and venture capital Asset Owners Asset owner solutions Asset servicing Fund services Governance, risk management, compliance and reporting ESG services Banking and treasury Portfolio monitoring and reporting Corporate a … isation services Special Purpose Vehicle (SPV) management services All services Fund and Asset Managers Asset Owners Debt, Capital Markets and Corporate Asset classes & fund types Impact funds Digital assets Hedge funds Hybrid, evergreen and semi-liquid funds Real assets services Private debt and credit Open-ended funds Private equity and venture capital View full offering Key services Alternative investment fund manager (AIFM) services AML and KYC services Asset servicin … services Asset servicing CFO support services Data services Depositary services Fund administration services IQ-EQ Switch Outsourcing Portfolio monitoring and reporting Regulatory compliance services Close Asset Owners Single family office Multi Family office Ultra High Net Worth individuals Sovereign Wealth Funds Insurance Pension and endowments View full offering Services Asset owner solutions Asset servicing Fund services Governance, risk management, compliance and reporti … es Gordian Capital Limited, Asia’s first and largest institutional cross-border fund platform and fund solutions provider IQ-EQ acquires Gordian Capital Limited, Asia’s first and largest institutional cross-border fund platform and fund solutions provider Published: 22 Jul 2025 | Updated: 23 Oct 2025 IQ-EQ, an Astorg portfolio company, has announ
Biocom California Announces the 10th Annual Life Science Catalyst Award Winners - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Biocom California Announces the 10th Annual Life Science Catalyst Award Winners October 28, 2025 | 2 min read Twitter LinkedIn Facebook Email Print 12 life science trailblazers under the age of 40 recognized across California SAN FRANCISCO & LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)-- Biocom Califo … tion and accomplishments. In alphabetical order, the 2025 Life Science Catalyst Award winners are: Alina (Tokmakova) Arzamassky, Ph.D., co-founder and co-managing director, Nucleate Bay Area; product manager and business development, Deep Origin Shreya Badhrinarayanan, M.D., global development lead, clinical development oncology and hematology, Pfizer Akash Bakshi, M.Sc., co-founder and CEO, YourChoice Therapeutics Martin Borch Jensen, Ph.D., chief scientific officer, Gordian … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Gordian Biotechnology Introduces High-Throughput In Vivo Screening Platform to Discover Therapies and Better Predict Human Outcomes for Age-Related Diseases - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Developm … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Biotech Bay Gordian Biotechnology Introduces High-Throughput In Vivo Screening Platform to Discover Therapies and Better Predict Human Outcomes for Age-Related Diseases April 26, 2024 | 6 min read Twitter LinkedIn Facebook Email Print Gordian Biotechnology, an in vivo drug discovery and development company, announced it … e company has raised $60 million to date from investors including The Longevity Fund, Arctica Ventures, Athos Service GmbH, Gigafund, Founders Fund, Fifty Years, and former Novartis CEO Thomas Ebeling. Gordian's Osteoarthritis (OA) program has screened hundreds of therapies in horses that acquired OA naturally and advanced dozens of therapies into human ex vivo validation studies. The results of these ex vivo studies matched screen predictions with 80% accuracy, and several h … hat can capture this complexity," said Laura Deming, a partner at The Longevity Fund and Gordian investor. "Our ability to understand these diseases is bottlenecked by the rate we can run tests in these living systems. Scaling that rate by over 100 fold is really exciting and is a huge leap toward curing age-related disease." In addition to MASH and OA, Gordian's current focus indications include heart failure with preserved ejection fraction and pulmonary fibrosis. The platf … ower. The company is funded by world-renowned investors including The Longevity Fund, Athos Service GmbH, Gigafund, Founders Fund, and former Novartis CEO Thomas Ebeling. Gordian: Creating Time. View original content to download multimedia: https://www.prnewswire.com/news-releases/gordian-biotechnology-introduces-high-throughput-in-vivo-screening
Gordian Bio Announces Research Collaboration with Pfizer to Accelerate In Vivo Target Discovery in Obesity - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Ce … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Gordian Bio Announces Research Collaboration with Pfizer to Accelerate In Vivo Target Discovery in Obesity January 8, 2026 | 2 min read Twitter LinkedIn Facebook Email Print Pfizer collaboration applies Gordian’s large-scale in vivo mosaic screening platform to prioritize novel obesity targets directly wi … diseases, today announced a non-exclusive research collaboration with Pfizer to apply Gordian’s proprietary in vivo mosaic screening platform to accelerate the discovery of therapeutic targets for obesity. Under the terms of the collaboration, Gordian will perform a screen of hundreds of gene targets directly within visceral adipose tissue. Unlike traditional ex vivo or single-target models, Gordian’s platform can obtain in vivo transcriptional readouts for hundreds of target … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Gordian Bio Releases Preprint Demonstrating Scalable In Vivo Mosaic Screening Platform to Establish Causal Disease Biology - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Busine … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Gordian Bio Releases Preprint Demonstrating Scalable In Vivo Mosaic Screening Platform to Establish Causal Disease Biology March 4, 2026 | 4 min read Twitter LinkedIn Facebook Email Print SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #biotech -- Gordian Biotechnology , a biotechnology company focused on … cing, known as perturb-seq, were developed to address this challenge, but their application has largely been confined to in vitro systems or narrowly scoped in vivo models. In the newly released preprint, Gordian describes a platform that extends large-scale pooled in vivo screening across multiple species and tissue contexts. A computational framework for predicting physiological endpoints from transcriptomic cell states allows ranking and prioritization of therapeutic poten … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Gordian's Job Order Contracting Awards | Gordian --> Skip to content Login Gordian Cloud Platform eGordian Sightlines Member Portal RSMeans Data Online VFA Support Portal Logo Home Solutions For Contractors Job Order Contracting Cost Estimating Bid Opportunities Commercial For Industry Owners A/E/C Commercial Federal Healthcare Higher Education K-12 State & Local Canada Public Sector UK Public Sector Co-op/GPO Partnerships By Capability Planning Develop data-driven capital strategies Procurement Deliver critical projects Optimization Maintain and improve asset performance View Platfor … press releases, newsletters and industry-related social media sites. Submit A Project Eligible Projects Nominees must have used a Gordian Job Order Contracting solution to complete a construction project in 2025. Projects completed with either a tailored Job Order Contract or a shared one (as in, those accessed via a purchasing cooperative) are eligible. Project owners, JOC contractors or Gordian employees may submit nominations. To be … ting. Enter your 2025 projects today. Submissions are open until April 8, 2026. Submit A Project Past Award of Excellence Winners County of Santa Cruz (CA) Accelerates Justice Discover how a California county built a state-of-the-art DNA processing lab to reduce turnaround time, creating a safer community faster than ever before. Watch The Video City Builds Wellness Center to Help Unhoused Locals Gordian’s Job Order Contracting hel … on consulting to its patients and the community of Atlanta. Read The Story Past Award of Merit Winners Customer Story, Video Summer Sprint: School Completes Multiple Renovations With Cooperative JOC Customer Story, Video City Repairs Storm-Damaged Roof in Days Using Job Order Contracting Customer Story Massachusetts Bay Transportation Authority (MBTA) Improves Three Stations During Brief Shutdown Customer Story City of San Mateo Creates Memorial to Honor Fallen Heroes Video M
%PDF-1.2 7 0 obj > stream q 600 0 0 805 0 0 cm /Im0 Do Q endstream endobj 5 0 obj > >> stream &��Gd|�GE�t^#�菑���G�" �N������#����;Kj����黵���UyS .��T6��z����-s4p�����͑������k�u3��8����l�D̐`�3���4ӽ��j��6F�f��������Z�3x'f+�����{���p�����������i��q G�b��������^� #��4������������Yi ���� ��x�T�?�-�""""$#��u~�_���� kA����������Я ���u�����A���� ����)�O��> ���[�� ^��/��%{���~�� ����^�������I���B"4f�) ��-������p�{n��O�Ų��ױ܉ �p��4��i��K&��o�?�������������_�w��>��YJ��N<>�ͯ����{�a+q��� �'n�:��_f���������o�?���᭮�x��o���7��{{��[i_�)����p\/��_��}��H_��܌�����O����ƈZ��W�;�]���z���V
Job Order Contracting Research Discussed on “Decisions That Matter” Podcast | Gordian --> Skip to content Login Gordian Cloud Platform eGordian Sightlines Member Portal RSMeans Data Online VFA Support Portal Logo Home Solutions For Contractors Job Order Contracting Cost Estimating Bid Opportunities Commercial For Industry Owners A/E/C Commercial Federal Healthcare Higher Education K-12 State & Local Canada Public Sector UK Public Sector Co-op/GPO Partnerships By Capability Planning Develop data-driven capital strategies Procurement Deliver critical projects Optimization Maintain and improv … osts. All Gordian JOC contracts are accessed in a secured, cloud-based software application. This purpose-built software allows owners to set milestones that tracks end dates, spend limits and key performance indicators for easy contract management. The Gordian team conducts a line-by line review of each project proposal to eliminate inefficiencies and confirm every relevant task necessary to complete the project is included. Gordian provides end -to-end support and JOC expe
Building Capacity: Engaging Educational Facilities Leadership l Episode 1 | Gordian --> Skip to content Login Gordian Cloud Platform eGordian Sightlines Member Portal RSMeans Data Online VFA Support Portal Logo Home Solutions For Contractors Job Order Contracting Cost Estimating Bid Opportunities Commercial For Industry Owners A/E/C Commercial Federal Healthcare Higher Education K-12 State & Local Canada Public Sector UK Public Sector Co-op/GPO Partnerships By Capability Planning Develop data-driven capital strategies Procurement Deliver critical projects Optimization Maintain and improve
PODCAST - UNTANGLING CLIMATE FINANCE - Gordian Knot Strategies Skip to content About Expand Clients Testimonials Team CarbonAccess Expand TRARO®: Impact Investment Screening Expand Download Guide – Smarter Climate Investing: 7 Strategic Filters Before Your First Impact Dollar Case Studies CapitalCatalyst Expand Impact Investing Expand TRARO®: Impact Investment Screening Impact Investor Information Form U.S. Endowment for Forestry & Communities – Impact Investing Program Case Studies StrategySphere Expand Case Studies Insights Expand Newsletter Expand SLICED – Weekly Newsletter … for Impact Credit Enhancement Facility for Assurance & Risk (CEFAR) Climate RFP Tracker CONTACT Search Toggle Menu PODCAST UNTANGLING CLIMATE FINANCE Hosted by Jay Tipton SUBSCRIBE Untangling Climate Finance is a podcast that explores the dynamic field of climate change finance through conversations with industry experts about topics including climate solutions, global carbon markets, carbon projects, novel technologies, and much more. Register for Untangling Climate Fina … ggie Monast , Senior Director, Climate-Smart Agriculture, Environmental Defense Fund (EDF) , unpacks how agriculture finance is moving from awareness to action on climate risk, and why it’s now a material business issue for lenders, what farmers need to adopt climate-smart practices, and how blended finance paired with value-chain incentives (especially in dairy) can make proven methane solutions bankable and unlock significant commercial capital. Click any of the links below … Carbon Aggregation Platform, and how climate finance can move beyond grants to fund resilient, long-term infrastructure. Click any of the links below to listen! EPISODE 7: NAVIGATING CARBON MARKET RISK WITH MARIA FILMANOVIC July 22nd, 2025 In this episode, Maria Filmanovic , Co-Founder and Director of Abatable , explores how risk, transparency, and data are reshaping the voluntary carbon market. She discusses Abatable’s approach to high-integrity carbon procureme … ESTATION February 20th, 2024 In this episode, Jay speaks with Grant Canary (Founder & CEO) and Jonathan Loevner (VP, Carbon Markets & Policy) of Mast Reforestation to discuss the post-wildfire reforestation work their company is doing. They discuss a recent stream financing agreement they made whi
Podcasts | Gordian --> Skip to content Login Gordian Cloud Platform eGordian Sightlines Member Portal RSMeans Data Online VFA Support Portal Logo Home Solutions For Contractors Job Order Contracting Cost Estimating Bid Opportunities Commercial For Industry Owners A/E/C Commercial Federal Healthcare Higher Education K-12 State & Local Canada Public Sector UK Public Sector Co-op/GPO Partnerships By Capability Planning Develop data-driven capital strategies Procurement Deliver critical projects Optimization Maintain and improve asset performance View Platform Capabilities Products Gordian Clo
Decoding Diseases of Aging...Dr. Martin Borch Jensen and Dr. Francisco LePort, Gordian Biotechnology - BioTech Nation ... with Dr. Moira Gunn | Podcast on Spotify
BioTech Nation ... with Dr. Moira Gunn | Transcript: Reprogramming the Future... Dr. Martin Borch Jensen and Dr. Francisco LePort, Gordian Biotechnology BioTech Nation ... with Dr. Moira Gunn Home Episodes About Dr. Gunn Media Info JPM 2026 BTN "5" BIO 2026 Subscribe menu close Home Episodes About Dr. Gunn Media Info JPM 2026 BTN "5" BIO 2026 Subscribe play pause Reprogramming the Future... Dr. Martin Borch Jensen and Dr. Francisco LePort, Gordian Biotechnology January 29, 2025 / 25:12 / E25004 Show Notes / Transcript Dr. Moira Gunn: 00:00 Working on what are usually consid
Podcast recap: Exploring aging research with Martin Borch Jensen of Gordian Biotechnology For patients Get in touch Solutions Solutions → For sponsors For CROs For sites Portal Services Services → Recruitment support Protocol development DNA testing Electronic medical record retrieval Patient engagement Prescreening and digital consent Resources Resources → Blog Case studies Whitepapers The Genetics Podcast Reports Webinars About Us --> Solutions ← Back Solutions For sponsors For CROs For sites Portal Services ← Back Services Recruitment support Protocol development DNA testing Electronic medi
Francisco Leport - Co-founder & CEO, Gordian Biotechnology | YesPress GORDIAN BIOTECHNOLOGY PARTNERS WITH PFIZER ON OBESITY DRUG DISCOVERY - JAN 2026 $60M SERIES A BACKED BY FOUNDERS FUND, GIGAFUND & THE LONGEVITY FUND 80% ACCURACY IN PREDICTING HUMAN CLINICAL OUTCOMES VIA MOSAIC SCREENING FRANCISCO LEPORT: CO-FOUNDER & CEO, GORDIAN BIOTECHNOLOGY STANFORD PHD IN NEUTRINO PHYSICS - TESLA BATTERY ENGINEER - BIOTECH FOUNDER GORDIAN BIO: TESTING HUNDREDS OF THERAPIES SIMULTANEOUSLY IN A SINGLE ANIMAL BIO INTERNATIONAL CONVENTION 2026 SPEAKER GORDIAN BIOTECHNOLOGY PARTNERS WITH PFIZER ON OBESITY DR … TH PFIZER ON OBESITY DRUG DISCOVERY - JAN 2026 $60M SERIES A BACKED BY FOUNDERS FUND, GIGAFUND & THE LONGEVITY FUND 80% ACCURACY IN PREDICTING HUMAN CLINICAL OUTCOMES VIA MOSAIC SCREENING FRANCISCO LEPORT: CO-FOUNDER & CEO, GORDIAN BIOTECHNOLOGY STANFORD PHD IN NEUTRINO PHYSICS - TESLA BATTERY ENGINEER - BIOTECH FOUNDER GORDIAN BIO: TESTING HUNDREDS OF THERAPIES SIMULTANEOUSLY IN A SINGLE ANIMAL BIO INTERNATIONAL CONVENTION 2026 SPEAKER CEO & Co-founder Biotech founder - Drug … illion Series A, closed in April 2024, came in from a revealing group: Founders Fund, Gigafund, The Longevity Fund, Arctica Ventures, Fifty Years, Athos Service GmbH, and Thomas Ebeling, the former CEO of Novartis. The mix of deep-tech venture capital and pharma credibility signals something. Big pharma is watching. In January 2026, Pfizer formalized that attention into a non-exclusive research collaboration to accelerate in vivo target discovery for obesity drug development. … vine Stage Series A Employees ~40 Investors - $60M Series A (Apr 2024) Founders Fund Gigafund The Longevity Fund Arctica Ventures Fifty Years Athos Service GmbH Thomas Ebeling (ex-Novartis CEO) Disease Programs OA Osteoarthritis MASH Metabolic-assoc. Steatohepatitis HFpEF Heart Failure (preserved EF) PF Pulmonary Fibrosis OB Obesity (w/ Pfizer, 2026) Career Before Gordian ~2009-2010 Stanford EXO-200 Experiment Experimental neutrino physics, liquid xenon detector ~2010-2012 Te … e platform's first major validation Apr 2024 Raises $60M Series A from Founders Fund, Gigafund, The Longevity Fund, and others. Publicly launches high-throughput in vivo screening platform with 80% osteoarthritis clinical outcome accuracy. Jan 2026 Announces non-exclusive research collaboration with Pfizer to accelerate in vivo target discovery f
ICYMI, co-founders Francisco LePort and Martin Borch Jensen were guests of Dr. Moira Gunn on the BioTech Nation podcast. It ran on our hometown NPR station KQED and about 200 other NPR affiliates. | Gordian Biotechnology LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choic
Francisco LePort & Martin Borch Jensen: The Biotech Founders Testing 25 Drugs in One Horse | Frameshifts Episode #3 Frameshifts with Benjamin Arya Subscribe Sign in Playback speed × Share post Share post at current time Share from 0:00 0:00 / Transcript 4 1 Francisco LePort & Martin Borch Jensen: The Biotech Founders Testing 25 Drugs in One Horse | Frameshifts Episode #3 "We're not even close to cracking aging." Oct 01, 2025 4 1 Share Transcript In this week’s episode, I sit down with Francisco LePort and Martin Borch Jensen, the co-founders of Gordian Biotechnology. Gordian
Best Practice Renewal Funding Model Born out of Gordian Partnership | Gordian --> Skip to content Login Gordian Cloud Platform eGordian Sightlines Member Portal RSMeans Data Online VFA Support Portal Logo Home Solutions For Contractors Job Order Contracting Cost Estimating Bid Opportunities Commercial For Industry Owners A/E/C Commercial Federal Healthcare Higher Education K-12 State & Local Canada Public Sector UK Public Sector Co-op/GPO Partnerships By Capability Planning Develop data-driven capital strategies Procurement Deliver critical projects Optimization Maintain and improve asset … newal Funding Model Born out of Gordian Partnership By Gordian A renewal fund with no project list A detailed assessment and prioritization of facilities needs A new industry-standard renewal funding model Challenge: All Funding, No Plan Claremont McKenna College had long operated in a culture of “no deferred maintenance” and had a Board of Trustees policy that set aside 1.2 times the annual depreciation expense in a reserve fund to cover renewal and replacement costs … rovide a flexible framework to quantify the annual transfers necessary to fully fund the needs of campus both now and into the future . Capital planning is one of the most important and most complex initiatives for a college or university. When done right, it can help meet today’s needs and work toward tomorrow’s goals. Learn more about how to build an effective long-term strategy in our free eBook, “From Assessment to Action: 4 Steps to Creating a Sustainab … y to replace the previous depreciation model. Annual transfers into the reserve fund are now determined by the cost of keep ing existing campus buildings up to date in a “like for like” model , which allows for replacing assets as they age. Any projects that go beyond this like-for-like renovation scope are reviewed and require re-approv al by the Board, including consideration of additional funding sources. The modeling of these renewal funds was then extended out 30 years b
Gordian Software | Leading API for Airline Ancillaries Solutions For Travel Platforms For Airlines About About us Careers Our Network News Blog Book a Demo MENU CLOSE Solutions For Travel Platforms For Airlines About About Us Careers Our Network News Blog Book a Demo Maximize Ancillary Revenue. Instantly. Gordian’s single API unlocks access to the industry’s most robust set of airline connections, ancillary products, and traveler insights alongside the top fulfillment infrastructure in the market. Trusted by 30+ platforms and airlines across the globe. Complexity: Cut Airlines. Ticket sources. … g at Gordian Software regardless. Press Release Gordian Receives Hot 25 Startup Award from a Leading Travel Industry News Site Gordian Software has been selected as one of Phocuswire’s Hot 25 Startups for 2022. News Airlines Are Getting Creative With Upselling—and It’s Driving Revenue Airlines are beginning their digital transformation. With Gordian, they can add millions in revenue with world-class data personalization. News This Startup Just Raised $25 Million To Help Airli … g at Gordian Software regardless. Press Release Gordian Receives Hot 25 Startup Award from a Leading Travel Industry News Site Gordian Software has been selected as one of Phocuswire’s Hot 25 Startups for 2022. View All Unlock the acceleration of Gordian Put the traveler in the heart of your technology and watch ancillary revenue soar. Book a Demo You're subscribed! Oops! Something went wrong while submitting the form. Solutions For Travel Platforms For Airlines Discover
Current Job Openings | Gordian Staffing | US Consent Preferences Home About Us About Our Hiring Process Our Mission, Vision & Values Philanthropy The Gordian Perspective Team Employer Why Gordian Staffing Pricing & Value Our Expertise Domestic Recruiting Employer of Record Popular Positions Cost Calculator FAQs – Our Clients Case Studies Candidates Work With Us Current Job Openings Learning & Growth RTM Success Stories FAQs – Careers RTM Portal Blog eBrochure Client Referral Contact Us U.S. Phone +1 989-467-3426 Email info @gordianstaffing.com A black and white drawing … alaries and Above Law benefits. Tips for a Successful Recruitment Process Submit your CV in English This ensures clear communication and helps us better understand your qualifications. Be Punctual Always join your interviews on time—first impressions matter. Test your Tech Beforehand Check your internet connection, microphone, and speakers to avoid last-minute issues. Dress Professionally Aim for business casual attire to reflect your seriousness and professionali … shoes, and all your home comforts! Item Link What to expect after submitting an application Slide title Write your caption here Button Submit your application through our job portal to start the process https://gordianstaffing.com/open-positions/ Slide title Write your caption here Button The Talent Acquisition team will carefully review your application and contact you if you meet the requirements. English level | Years of experience | Salary expectations Slide title Write y
Gordian Knot - Wikipedia Jump to content Main menu Main menu move to sidebar hide Navigation Main page Contents Current events Random article About Wikipedia Contact us Contribute Help Learn to edit Community portal Recent changes Upload file Special pages Print/export Download as PDF Printable version In other projects Wikimedia Commons Wikidata item Search Search Appearance Donate Create account Log in Personal tools Donate Create account Log in Contents move to sidebar hide (Top) 1 Legend 2 Interpretations 3 See also 4 Explanatory notes 5 References 6 External links Toggle the table of cont … the Creative Commons Attribution-ShareAlike 4.0 License ; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy . Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc. , a non-profit organization. Privacy policy About Wikipedia Disclaimers Contact Wikipedia Legal & safety contacts Code of Conduct Developers Statistics Cookie statement Mobile view Search Search Toggle the table of contents Gordian Knot 51 languag